DETRUSITOL SR- tolterodine tartrate capsule, extended release 
Neolpharma, Inc.

----------

Detrusitol SR 4mg, Neolpharma as CMO

4mg 1s blister

4mg 1s carton

4mg 7s blister

4mg 7s carton

DETRUSITOL  SR
tolterodine tartrate capsule, extended release
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:55466-716
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TOLTERODINE TARTRATE (UNII: 5T619TQR3R) (TOLTERODINE - UNII:WHE7A56U7K) TOLTERODINE TARTRATE4 mg
Inactive Ingredients
Ingredient NameStrength
OLEIC ACID (UNII: 2UMI9U37CP)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
SUCROSE (UNII: C151H8M554)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
GELATIN (UNII: 2G86QN327L)  
ETHYLCELLULOSES (UNII: 7Z8S9VYZ4B)  
Product Characteristics
ColorblueScoreno score
ShapeCAPSULESize16mm
FlavorImprint Code 4;whitefreedomfigure
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:55466-716-701 in 1 CARTON02/22/2000
11 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:55466-716-7314 in 1 CARTON02/22/2000
27 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA02122802/22/2000
Labeler - Neolpharma, Inc. (078709787)
Registrant - Neolpharma, Inc. (078709787)
Establishment
NameAddressID/FEIBusiness Operations
Neolpharma, Inc.078709787pack(55466-716) , label(55466-716)
Establishment
NameAddressID/FEIBusiness Operations
Catalent Pharma Solutions LLC829672745manufacture(55466-716) , analysis(55466-716)

Revised: 10/2017
 
Neolpharma, Inc.